Barrington Research reiterated coverage on Blucora with a new price target
$BCOR
Investment Managers
Finance
Barrington Research reiterated coverage of Blucora with a rating of Outperform and set a new price target of $19.00 from $16.00 previously
Save time and jump to the most important pieces.
| Date | Price Target | Rating | Analyst |
|---|---|---|---|
| 7/11/2022 | $22.00 | Overweight | Cantor Fitzgerald |
| 12/14/2021 | $27.00 → $22.00 | Overweight → Neutral | JP Morgan |
DALLAS, Jan. 27, 2023 (GLOBE NEWSWIRE) -- Avantax, Inc. (NASDAQ:AVTA) (formerly known as Blucora, Inc., the "Company") announced today that it has commenced a modified "Dutch auction" tender offer (the "Tender Offer") to purchase for cash up to $250 million of its common stock, par value $0.0001 per share ("Common Stock"), at a price per share not less than $27.00 and not greater than $31.00, less any applicable withholding taxes and without interest, using proceeds from the Company's recent sale of its tax software business, which closed on December 19, 2022, and borrowings under the Company's credit facility. The Tender Offer will expire at 12:00 midnight, New York City time, at the end
DALLAS, Jan. 26, 2023 (GLOBE NEWSWIRE) -- Avantax, Inc. (NASDAQ:AVTA) (formerly known as Blucora, Inc. (NASDAQ: BCOR)), a leading provider of tax-focused wealth management services, today announced that Tabitha Bailey has been appointed Chief Legal Officer and Corporate Secretary, succeeding Ann J. Bruder, who has stepped down from her role as Chief Legal, Development and Administration Officer after nearly six years in the role. Ms. Bruder has agreed to continue to work with Avantax in a consulting role through the end of June to support the transition. "Tabitha has been a meaningful member of the Avantax team since she first joined the company, and we are very pleased to announce her ap
DALLAS, Jan. 25, 2023 (GLOBE NEWSWIRE) -- Blucora, Inc. (NASDAQ:BCOR), a leading provider of tax-focused wealth management services, today announced a corporate name change to Avantax, Inc. and a change of its NASDAQ ticker symbol from "BCOR" to "AVTA" effective as of 12:01 a.m. Eastern Time on Thursday, January 26, 2023 (the "Effective Date"). Despite this name change, the CUSIP number (095229100) remains unchanged. On the Effective Date, the Company's common stock will be quoted under the new name "Avantax, Inc.," and the Company's ticker symbol will be updated to "AVTA." No action is required by existing Blucora stockholders with respect to the name or ticker change. The Company's Chi
Cantor Fitzgerald initiated coverage of Blucora with a rating of Overweight and set a new price target of $22.00
JP Morgan downgraded Blucora from Overweight to Neutral and set a new price target of $22.00 from $27.00 previously
The Benchmark Company reiterated coverage of Blucora with a rating of Buy and set a new price target of $24.00 from $21.00 previously
SC 13G - AVANTAX, INC. (0001068875) (Subject)
SC 13G/A - AVANTAX, INC. (0001068875) (Subject)
SC 13G/A - AVANTAX, INC. (0001068875) (Subject)
4 - AVANTAX, INC. (0001068875) (Issuer)
4 - AVANTAX, INC. (0001068875) (Issuer)
4 - AVANTAX, INC. (0001068875) (Issuer)
15-12G - AVANTAX, INC. (0001068875) (Filer)
EFFECT - AVANTAX, INC. (0001068875) (Filer)
EFFECT - AVANTAX, INC. (0001068875) (Filer)
DALLAS, Jan. 26, 2023 (GLOBE NEWSWIRE) -- Avantax, Inc. (NASDAQ:AVTA) (formerly known as Blucora, Inc. (NASDAQ: BCOR)), a leading provider of tax-focused wealth management services, today announced that Tabitha Bailey has been appointed Chief Legal Officer and Corporate Secretary, succeeding Ann J. Bruder, who has stepped down from her role as Chief Legal, Development and Administration Officer after nearly six years in the role. Ms. Bruder has agreed to continue to work with Avantax in a consulting role through the end of June to support the transition. "Tabitha has been a meaningful member of the Avantax team since she first joined the company, and we are very pleased to announce her ap
DALLAS, March 11, 2022 (GLOBE NEWSWIRE) -- Blucora, Inc. (NASDAQ:BCOR), a leading provider of technology-enabled, tax-focused financial solutions, today announced the appointment of Kan Kotecha and Rick Leaman to the Company's Board of Directors, effective immediately. The appointments complete a search process initiated in 2021 by the Blucora Board of Directors, which was conducted with the input of Blucora's shareholders and the assistance of a leading executive search firm. Mr. Kotecha is currently a Vice President of Engineering at Google Inc. and previously served as Chief Technology Officer at Morgan Stanley Wealth Management where he led a team of over 600 professionals. He bring
DALLAS, May 05, 2021 (GLOBE NEWSWIRE) -- Blucora, Inc. (NASDAQ:BCOR), a leading provider of technology-enabled, tax focused financial solutions, today announced financial results for the first quarter ended March 31, 2021. First Quarter Highlights and Recent Developments Increased total revenue for the quarter to $278.4 million, or 6% year-over-yearGAAP Net Income of $27.6 million, or $0.56 per diluted shareNon-GAAP Net Income of $51.0 million, or $1.04 per diluted shareTotal client assets ended the quarter up 39% year over year to $84.8 billion, with $36.8 billion, or 43.4% in advisory assetsAdvisory assets increased 56% year-over-year, including the addition of approximately $5.0 billi
Benzinga Pro data, Blucora (NASDAQ:BCOR) reported Q3 sales of $171.70 million. Earnings fell to a loss of $21.84 million, resulting in a 155.4% decrease from last quarter. Blucora earned $39.42 million, and sales totaled $256.88 million in Q2. Why Is ROIC Significant? Return on Invested Capital is a measure of yearly pre-tax profit relative to capital invested by a business. Changes in earnings and sales indicate shifts in a company's ROIC. A higher ROIC is generally representative of successful growth of a company and is a sign of higher earnings per share in the future. A low or negative ROIC suggests the opposite. In Q3, Blucora posted an ROIC of 4.66%. Keep in mind, while ROIC is a good
Gainers Abiomed, Inc. (NASDAQ:ABMD) shares surged 49.9% to settle at $377.82 on Tuesday after Johnson & Johnson announced it will acquire the company . Also, the company reported better-than-expected Q2 adjusted EPS results. Sonnet BioTherapeutics Holdings, Inc. (NASDAQ:SONN) gained 46.6% to close at $2.83. Sonnet BioTherapeutics recently announced an agreement with Janssen for the evaluation of three Sonnet product candidates. NLS Pharmaceutics AG (NASDAQ:NLSP) gained 44% to settle at $0.74. NLS Pharmaceutics was granted FDA Orpha Drug Designation for Quilience (Mazindol) for the treatment of idiopathic hypersomnia. Ucommune International Ltd (NASDAQ:UK) jumped 34.7% to close at $1.
U.S. stocks closed lower on Tuesday, with the Nasdaq Composite dropping around 100 points. Here is the list of some big stocks recording gains in the previous session. Abiomed, Inc. (NASDAQ:ABMD) shares surged 49.9% to settle at $377.82 on Tuesday after Johnson & Johnson announced it will acquire the company. Also, the company reported better-than-expected Q2 adjusted EPS results. Harsco Corporation (NYSE:HSC) climbed 22.5% to close at $6.48 after the company reported better-than-expected Q3 sales results and raised FY22 adjusted EPS guidance. Harmony Biosciences Holdings, Inc. (NASDAQ:HRMY) rose 14% to settle at $59.26 after the company reported better-than-expected Q3 EPS and sales r
DALLAS, Nov. 01, 2022 (GLOBE NEWSWIRE) -- Blucora, Inc. (NASDAQ:BCOR), a leading provider of technology-enabled, tax focused financial solutions, today announced financial results for the third quarter ended September 30, 2022. Third Quarter Highlights and Recent Developments Avantax added newly recruited assets of $214 million during the third quarter for a total of approximately $1.3 billion during the first nine months of 2022. This exceeds full year 2021 newly recruited assets of $929 million.Avantax continued to deliver net positive asset flows with $380 million for the quarter and $810 million year to date.Blucora reported total revenue of $171.7 million, a decrease of 1% v
Has Entered Into Definitive Agreement to Sell Tax Software Business for $720 Million in Cash Company to Use Proceeds to Pay Down Debt and Return Excess Capital to Shareholders Company to Streamline Operations and Rebrand as Avantax after the Closing of the TaxAct Transaction Blucora to Host Conference Call Today at 8:30 a.m. ET DALLAS, Nov. 01, 2022 (GLOBE NEWSWIRE) -- Blucora, Inc. ("Blucora" or the "Company") (NASDAQ:BCOR) today announced that it has agreed to sell TaxAct, its tax software business. Under the terms of the transaction, an affiliate of Cinven will purchase TaxAct for $720 million in cash, subject to adjustment. The transaction is expected to close by the end of 2022.
DALLAS, Oct. 26, 2022 (GLOBE NEWSWIRE) -- Blucora, Inc. (NASDAQ:BCOR), a provider of data and technology-driven tax software and wealth management solutions that empowers people to improve their financial wellness, will announce its third quarter 2022 financial results prior to market open on Tuesday, November 1, 2022. A conference call for members of the investment community will be held on Tuesday, November 1, 2022 at 8:30 a.m. ET during which the Company will discuss its third quarter 2022 results, its outlook and other business items. This call will be webcast and can be accessed within the Investor Relations section of the Blucora corporate website at www.blucora.com. About Blucora®